Literature DB >> 20449406

A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applications.

Dannon J Stigers1, Riccardo Ferdani, Gary R Weisman, Edward H Wong, Carolyn J Anderson, James A Golen, Curtis Moore, Arnold L Rheingold.   

Abstract

A phosphonate pendant-armed cross-bridged cyclam chelator has been synthesized, complexed to Cu(ii), radiolabeled with (64)Cu under mild conditions, and its biodistribution studied.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20449406     DOI： 10.1039/b920871b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN： 1477-9226            Impact factor:   4.390


  12 in total

1.  Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.

Authors:  Yunjun Guo; Riccardo Ferdani; Carolyn J Anderson
Journal:  Bioconjug Chem       Date:  2012-06-18       Impact factor: 4.774

Review 2.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

3.  Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms.

Authors:  Riccardo Ferdani; Dannon J Stigers; Ashley L Fiamengo; Lihui Wei; Barbara T Y Li; James A Golen; Arnold L Rheingold; Gary R Weisman; Edward H Wong; Carolyn J Anderson
Journal:  Dalton Trans       Date:  2011-12-15       Impact factor: 4.390

4.  Phosphonate Pendant Armed Propylene Cross-Bridged Cyclam: Synthesis and Evaluation as a Chelator for Cu-64.

Authors:  Nikunj Bhatt; Nisarg Soni; Yeong Su Ha; Woonghee Lee; Darpan N Pandya; Swarbhanu Sarkar; Jung Young Kim; Hochun Lee; Sun Hee Kim; Gwang Il An; Jeongsoo Yoo
Journal:  ACS Med Chem Lett       Date:  2015-10-20       Impact factor: 4.345

5.  H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.

Authors:  Gwendolyn A Bailey; Eric W Price; Brian M Zeglis; Cara L Ferreira; Eszter Boros; Michael J Lacasse; Brian O Patrick; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Inorg Chem       Date:  2012-10-29       Impact factor: 5.165

6.  Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.

Authors:  Majiong Jiang; Riccardo Ferdani; Monica Shokeen; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2012-12-23       Impact factor: 2.408

7.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

8.  Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes.

Authors:  Antoinette Y Odendaal; Ashley L Fiamengo; Riccardo Ferdani; Thaddeus J Wadas; Daniel C Hill; Yijie Peng; Katie J Heroux; James A Golen; Arnold L Rheingold; Carolyn J Anderson; Gary R Weisman; Edward H Wong
Journal:  Inorg Chem       Date:  2011-03-07       Impact factor: 5.165

9.  First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Authors:  Morten Persson; Dorthe Skovgaard; Malene Brandt-Larsen; Camilla Christensen; Jacob Madsen; Carsten H Nielsen; Tine Thurison; Thomas Levin Klausen; Søren Holm; Annika Loft; Anne Kiil Berthelsen; Michael Ploug; Helle Pappot; Klaus Brasso; Niels Kroman; Liselotte Højgaard; Andreas Kjaer
Journal:  Theranostics       Date:  2015-09-13       Impact factor: 11.556

10.  Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice.

Authors:  Dexing Zeng; Yunjun Guo; Alexander G White; Zhengxin Cai; Jalpa Modi; Riccardo Ferdani; Carolyn J Anderson
Journal:  Mol Pharm       Date:  2014-04-25       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.